The chemical class known as UIP5 inhibitors encompasses a range of compounds that can inhibit the UIP5 protein, a U-box domain-containing protein involved in crucial cellular processes. These inhibitors target various aspects of UIP5's function and interaction pathways, offering a diverse approach to modulating its activity. The primary focus of UIP5 inhibitors is on disrupting the protein degradation pathway, specifically the ubiquitin-proteasome system where UIP5 plays a pivotal role as an E3 ubiquitin ligase. By inhibiting this system, these compounds can alter the dynamics of protein degradation, potentially leading to an increase in the substrate load on UIP5. This can effectively reduce UIP5's functional capacity, as the protein may become overwhelmed or unable to effectively tag proteins for degradation. Proteasome inhibitors are a key category in this class, directly impacting the degradation pathway in which UIP5 is involved. By hindering the proteasome's ability to degrade ubiquitinated proteins, these inhibitors indirectly influence UIP5's role in tagging proteins for degradation, thereby modulating its overall activity.
Additionally, UIP5 inhibitors include compounds that target the interactions between UIP5 and heat shock proteins (Hsps), particularly Hsp70. This interaction is critical for UIP5's function in protein quality control and degradation. Inhibitors that disrupt these interactions, typically Hsp90 inhibitors, can affect UIP5's chaperone-mediated functions. These compounds bind to Hsp90 and alter its activity, which in turn can disrupt the functional interplay between Hsp70 and UIP5, impacting UIP5's ability to regulate protein quality control. Moreover, some inhibitors in this class function by inducing a cellular stress response, which can lead to an increased demand on the protein quality control system, indirectly affecting UIP5's capacity to handle misfolded or damaged proteins. This method of inhibition is particularly relevant in the context of cellular homeostasis, where the balance of protein folding and degradation is critical. By modulating this balance, UIP5 inhibitors can influence the overall function of UIP5 in maintaining protein homeostasis. In summary, UIP5 inhibitors are a diverse group of compounds that target various aspects of UIP5's role in protein degradation and quality control. Through different mechanisms of action, these inhibitors can modulate the activity of UIP5, impacting its ability to function effectively in crucial cellular processes. Whether by directly affecting the proteasome, disrupting chaperone interactions, or inducing cellular stress responses, each inhibitor offers a unique approach to influencing UIP5 activity. This class of compounds represents an important area of focus for modulating the function of UIP5 in various cellular contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that could possibly inhibit UIP5 by increasing the substrate load on it, affecting its function. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
An Hsp90 inhibitor; this could possibly inhibit UIP5 by disrupting its interaction with Hsp70. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
A derivative of geldanamycin, also an Hsp90 inhibitor; could possibly inhibit UIP5 by affecting its interactions with Hsps. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
An Hsp90 inhibitor that could possibly inhibit UIP5 by affecting its chaperone-mediated functions. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
A natural compound known to inhibit the proteasome and thus could possibly inhibit UIP5's role in protein degradation. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A specific proteasome inhibitor, which could possibly inhibit UIP5 by influencing the degradation pathway. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A proteasome inhibitor; could possibly inhibit UIP5 by modulating the proteasomal degradation pathway. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
An inhibitor of vacuolar-type H+-ATPase; could possibly inhibit UIP5 by impacting cellular degradation pathways. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Another Hsp90 inhibitor; could possibly inhibit UIP5 via its interaction with heat shock proteins. | ||||||